Clinical trial
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
NCT04039867 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
- Lead sponsor
- University of California, Irvine
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 20, 2005
- Completion date
- October 6, 2011
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.